The role of PARPs in diabetes has been explored for the last thirty years, with early studies employing PARP-inhibitors in isolated β cell function15,34, while later reports investigated the action using PARP1−/− mice or derived cells17–20. Here, PARP1 is linked to diabetes mellitus.